Founding Date | 2013 |
MabPlex total Funding | $130 m |
MabPlex latest funding size | $71 m |
Time since last funding | 2 years ago |
MabPlex investors | DT Capital Partners, Shenzhen Capital Group, OrbiMed, China Merchants Securities, SDIC Venture Capital, Huajin Capital, Sunshine Insurance Group, Qiandao Fund, Horus Capital, Finnova Capital, Yuce Biological Technology, Thousand Oaks Biopharmaceuticals, Hangzhou Kang Sheng Health Management, Apollomics, Apic Bio, Antagene |